A
$ Value
$0
Shares
20,000
Price
$0
Filed
Oct 23
Insider
Name
Hansen Gwenn
Title
Chief Scientific Officer
CIK
0001817160
Roles
Officer
Transaction Details
Transaction Date
2025-10-14
Code
A
Table
Derivative
Ownership
Direct
Equity Swap
No
Shares After
20,000
Footnotes
Each restricted stock unit ("RSU") represents a contingent right to receive one share of the Issuer's common stock. | The RSUs will vest on the second anniversary of the date of grant, subject to the Reporting Person's continuous services to the Issuer from the date of grant through such vesting date. Shares of the Issuer's common stock will be delivered to the Reporting Person following vesting. | RSUs do not expire; they either vest or are canceled prior to the vest date.
Filing Info
Hansen Gwenn's History
| Date | Ticker | Type | Value |
|---|---|---|---|
| 2026-02-10 | NRIX | A | $0 |
| 2026-02-10 | NRIX | A | $0 |
| 2026-02-03 | NRIX | M | $26K |
| 2026-02-03 | NRIX | M | $0 |
| 2026-01-30 | NRIX | M | $0 |
| 2026-01-30 | NRIX | M | $0 |
| 2026-01-30 | NRIX | M | $0 |
| 2026-01-30 | NRIX | M | $0 |
| 2026-01-30 | NRIX | ▼ | $80K |
| 2026-01-30 | NRIX | ▼ | $2K |
Other Insiders at NRIX (90d)
| Insider | Bought | Sold | Last |
|---|---|---|---|
|
SANDS ARTHUR T
President, CEO
|
— | — | 2026-02-10 |
|
Hansen Gwenn
Chief Scientific Officer
|
— | $81K | 2026-02-10 |
|
Ring Christine
Chief Legal Officer
|
— | $561K | 2026-04-02 |
|
van Houte Hans
Chief Financial Officer
|
— | $61K | 2026-02-10 |